High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.6M
$3,640,101
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 Sell
2026-02-25
$459,601
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 Sell
|
2026-02-25 | $459,601 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 Sell
2026-02-18
$589,258
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 Sell
|
2026-02-18 | $589,258 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 SellΔOwn -12.7%
2026-02-17
$1,211,903Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 SellΔOwn -12.7%
|
2026-02-17 | $1,211,903Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 Sell
2026-02-13
$493,012
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 Sell
|
2026-02-13 | $493,012 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 Sell
2026-02-11
$886,328
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 Sell
|
2026-02-11 | $886,328 | S | Form 4 |